VSee Health, Inc.
VSEE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $10,421 | $5,766 | $6,378 | $7,337 |
| % Growth | 80.7% | -9.6% | -13.1% | – |
| Cost of Goods Sold | $3,244 | $1,933 | $1,543 | $1,413 |
| Gross Profit | $7,178 | $3,833 | $4,835 | $5,924 |
| % Margin | 68.9% | 66.5% | 75.8% | 80.7% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $6,441 | $719 | $1,027 | $5,672 |
| SG&A Expenses | $11,860 | $5,380 | $6,299 | $283 |
| Sales & Mktg Exp. | $5,420 | $4,661 | $5,272 | -$5,389 |
| Other Operating Expenses | $57,468 | $327 | $216 | $5,389 |
| Operating Expenses | $69,328 | $5,706 | $6,515 | $5,672 |
| Operating Income | -$62,151 | -$1,874 | -$1,680 | $252 |
| % Margin | -596.4% | -32.5% | -26.3% | 3.4% |
| Other Income/Exp. Net | $2,806 | -$13 | $60 | $134 |
| Pre-Tax Income | -$59,345 | -$1,887 | -$1,620 | $386 |
| Tax Expense | -$1,643 | $1,838 | -$694 | $108 |
| Net Income | -$57,702 | -$3,763 | -$836 | $476 |
| % Margin | -553.7% | -65.3% | -13.1% | 6.5% |
| EPS | -5.65 | -0.38 | -0.084 | 0.048 |
| % Growth | -1,386.8% | -354.5% | -274.9% | – |
| EPS Diluted | -5.65 | -0.38 | -0.084 | 0.048 |
| Weighted Avg Shares Out | 10,213 | 9,998 | 9,999 | 9,946 |
| Weighted Avg Shares Out Dil | 10,213 | 9,998 | 9,998 | 9,946 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $359 | $923 | $2 |
| Interest Expense | $211 | $2,178 | $126 | $0 |
| Depreciation & Amortization | $1,323 | $1 | $1,464 | -$252 |
| EBITDA | -$3,359 | -$1,786 | $0 | $0 |
| % Margin | -32.2% | -31% | 0% | 0% |